Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDr. Martens Regulatory News (DOCS)

Share Price Information for Dr. Martens (DOCS)

Share Price is delayed by 15 minutes
Get Live Data
73.60    -0.30 (-0.41%)
Bid:
73.60
Ask:
73.90
Spread: 0.30 (0.408%)
Market Cap: £704.42m
DOCS Live PriceLast checked at - London Stock Exchange

Intraday Dr. Martens Share Chart

Directorate Change

24 Mar 2023 07:00

RNS Number : 0822U
Dr. Martens PLC
24 March 2023
 

Dr. Martens plc

APPOINTMENT OF NON-EXECUTIVE DIRECTOR

 

Dr. Martens plc ('the Company') today announces that, following a comprehensive search and selection process, Andrew Harrison will join the Board as an Independent Non-Executive Director with effect from 1 May 2023.

 

Andrew is a managing partner at consumer brand investment firm Freston Ventures and Senior Independent Director at Ocado Group plc, proprietor of the Ocado Smart Platform and joint owner of online grocer Ocado Retail Limited, where he is also chair of the Remuneration Committee and designated Non-Executive Director for engagement with the workforce. He built his executive career over more than two decades at Carphone Warehouse, where he served as Chief Executive and Chair. As a member of the early founding team, he drove the growth and international expansion of Carphone Warehouse from a small, privately owned retailer to established market leader and FTSE constituent, subsequently leading the merger of the business with Dixons in 2014, where he was Deputy Chief Executive.

 

Paul Mason, Chairman, said:

 

"I am delighted to welcome Andrew to the Dr. Martens Board. He brings a wealth of expertise of consumer facing and technology focused businesses and a highly entrepreneurial mindset. His significant prior experience as both a Chief Executive and Non-Executive Director of large, listed companies will bolster the Board and will be invaluable to the business as we embark on the next chapter of the Dr. Martens story."

 

On joining the Board, Andrew will also become a member of the Audit, Remuneration and Nomination Committees.

 

The Company confirms that there is no further information required to be disclosed pursuant to paragraph 9.6.13 of the UK Listing Rules.

 

 

Enquiries

 

Investors and analysts

Mark Blythman, Interim Director of Investor Relations +44 7570 871207

mark.blythman@drmartens.com

Media

Gill Hammond, Director of Communications +44 7384 214248

 

H/Advisors Maitland

Rhys Jones +44 7881 996460

 

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens has since transcended its working-class roots while still celebrating its proud heritage and, six decades later, "Docs" or "DMs" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. 

 

The Company listed successfully on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASEAFUDEDSEED
Date   Source Headline
1st Aug 202511:51 amRNSTotal Voting Rights
28th Jul 20258:53 amRNSDirector/PDMR Shareholding
14th Jul 20253:08 pmRNSDirector/PDMR Shareholding
10th Jul 202510:58 amRNSResult of 2025 AGM
10th Jul 20257:00 amRNSAGM Trading Update
4th Jul 20251:56 pmRNSTotal Voting Rights
17th Jun 202510:00 amRNSDirector/PDMR Shareholding
17th Jun 20259:00 amRNSAnnual Financial Report
12th Jun 20254:13 pmRNSDirector/PDMR Shareholding
5th Jun 20257:00 amRNSFinal Results
2nd Jun 20252:05 pmRNSBlock listing Interim Review
30th May 202510:52 amRNSTotal Voting Rights
27th May 20258:45 amRNSDirector Declaration
14th May 20252:20 pmRNSDirector/PDMR Shareholding
1st May 20254:02 pmRNSTotal Voting Rights
16th Apr 20254:00 pmRNSDirector/PDMR Shareholding
9th Apr 20253:00 pmRNSDirector/PDMR Shareholding
31st Mar 20259:38 amRNSTotal Voting Rights
26th Mar 202510:00 amRNSDirector/PDMR Shareholding
12th Mar 20252:26 pmRNSDirector/PDMR Shareholding
28th Feb 202511:01 amRNSTotal Voting Rights
12th Feb 20254:35 pmRNSDirector/PDMR Shareholding
12th Feb 20257:00 amRNSAppointment of Non-Executive Directors
31st Jan 202510:36 amRNSTotal Voting Rights
27th Jan 20257:00 amRNSQ3 FY25 Trading Statement
15th Jan 20256:14 pmRNSDirector/PDMR Shareholding
2nd Jan 202512:02 pmRNSTotal Voting Rights
20th Dec 20243:07 pmRNSHolding(s) in Company
13th Dec 202411:54 amRNSDirector/PDMR Shareholding
12th Dec 20247:00 amRNSBlock Listing Application
2nd Dec 202410:43 amRNSBlock listing Interim Review
2nd Dec 202410:10 amRNSTotal Voting Rights
28th Nov 20247:01 amRNSConfirmation of new CEO start date
28th Nov 20247:00 amRNSHalf-year Report
12th Nov 20243:56 pmRNSDirector/PDMR Shareholding
31st Oct 20243:23 pmRNSTotal Voting Rights
15th Oct 20243:19 pmRNSDirector/PDMR Shareholding
2nd Oct 20241:55 pmRNSDirector/PDMR Shareholding
30th Sep 202410:24 amRNSTotal Voting Rights
26th Sep 20242:00 pmRNSTransaction by PCA of PDMR
25th Sep 20247:00 amRNSHolding(s) in Company
24th Sep 202410:53 amRNSDirector/PDMR Shareholding
23rd Sep 20244:31 pmRNSHolding(s) in Company
12th Sep 20243:13 pmRNSDirector/PDMR Shareholding
30th Aug 20243:19 pmRNSTotal Voting Rights
27th Aug 202411:58 amRNSDirector/PDMR Shareholding
20th Aug 20243:48 pmRNSDirector/PDMR Shareholding
12th Aug 202411:30 amRNSHolding(s) in Company
31st Jul 20243:43 pmRNSTotal Voting Rights
12th Jul 202412:42 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.